Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin

Background & Aims: Proton pump inhibitors (PPIs) are effective at treating acid-related disorders. These drugs are well tolerated in the short term, but long-term treatment was associated with adverse events in observational studies. We aimed to confirm these findings in an adequately powered ra...

Full description

Bibliographic Details
Published in:Gastroenterology
Main Author: 2-s2.0-85070685740
Format: Article
Language:English
Published: W.B. Saunders 2019
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85070685740&doi=10.1053%2fj.gastro.2019.05.056&partnerID=40&md5=85e2dcf3a6f3f0e5a4657b8440522fdb